Volume 17, Issue 3, Pages (March 2018)

Slides:



Advertisements
Similar presentations
Crohn's disease Prof Daniel C Baumgart, MD, Prof William J Sandborn, MD The Lancet Volume 380, Issue 9853, Pages (November 2012) DOI: /S (12)
Advertisements

Volume 390, Issue 10089, Pages (July 2017)
Volume 389, Issue 10076, Pages (April 2017)
Volume 388, Issue 10059, Pages (November 2016)
Total and cause-specific mortality before and after the onset of the Greek economic crisis: an interrupted time-series analysis  Ioannis Laliotis, PhD,
Demographic and practice factors predicting repeated non-attendance in primary care: a national retrospective cohort analysis  David A Ellis, PhD, Ross.
The commercial determinants of health
Helen Cox, Mark P Nicol  The Lancet Infectious Diseases 
Risk of cancer associated with residential exposure to asbestos insulation: a whole- population cohort study  Dr Rosemary J Korda, PhD, Mark S Clements,
Volume 5, Issue 4, Pages (April 2006)
Natural environments and suicide mortality in the Netherlands: a cross-sectional, ecological study  Marco Helbich, PhD, Derek de Beurs, PhD, Prof Mei-Po.
Frailty and pre-frailty in middle-aged and older adults and its association with multimorbidity and mortality: a prospective analysis of 493 737 UK Biobank.
Volume 15, Issue 2, Pages (February 2016)
Volume 389, Issue 10071, Pages (February 2017)
Charity begins at home in global health research funding
Pollution and non-communicable disease: time to end the neglect
Volume 4, Issue 12, Pages (December 2017)
Andrea Ganna, PhD, Prof Erik Ingelsson, MD  The Lancet 
Volume 15, Issue 13, Pages (December 2016)
Do air quality alerts benefit public health? New evidence from Canada
Nicola Low, Joost H Smid  The Lancet Public Health 
Effective cross-sector collaborations create sustainability
Volume 391, Issue 10121, Pages (February 2018)
Socioeconomic disparities in first stroke incidence, quality of care, and survival: a nationwide registry-based cohort study of 44 million adults in England 
Developing biomarkers for cerebral amyloid angiopathy trials: do potential disease phenotypes hold promise?  Andreas Charidimou, Hans Rolf J Jäger  The.
The effect of explosive remnants of war on global public health: a systematic mixed- studies review using narrative synthesis  Alexandra Frost, MSc, Prof.
National, regional, and global prevalence of smoking during pregnancy in the general population: a systematic review and meta-analysis  Shannon Lange,
Volume 388, Issue 10059, Pages (November 2016)
Arnaud Chiolero  The Lancet Public Health 
A clinical prediction model for cancer-associated venous thromboembolism: a development and validation study in two independent prospective cohorts  Prof.
Volume 4, Issue 6, Pages (June 2017)
Can an iPhone App help stroke physicians?
Changes in chlamydia prevalence and duration of infection estimated from testing and diagnosis rates in England: a model-based analysis using surveillance.
Volume 11, Issue 3, Pages (March 2012)
Volume 393, Issue 10171, Pages (February 2019)
Premature mortality projections in the USA through 2030: a modelling study  Ana F Best, PhD, Emily A Haozous, PhD, Amy Berrington de Gonzalez, dPhil, Pavel.
Trends in infant mortality in Venezuela between 1985 and 2016: a systematic analysis of demographic data  Jenny García, MSc, Prof Gerardo Correa, MSc,
Risk of poor development in young children in low-income and middle-income countries: an estimation and analysis at the global, regional, and country.
Volume 17, Issue 2, Pages (February 2018)
Tranexamic acid for hyperacute primary IntraCerebral Haemorrhage (TICH-2): an international randomised, placebo-controlled, phase 3 superiority trial 
Emerging cancer trends among young adults in the USA: analysis of a population-based cancer registry  Hyuna Sung, PhD, Rebecca L Siegel, MPH, Philip S.
Volume 390, Issue 10089, Pages (July 2017)
Whole-genome sequencing to determine transmission of Neisseria gonorrhoeae: an observational study  Dilrini De Silva, PhD, Joanna Peters, MBBS, Kevin.
Measuring population ageing: an analysis of the Global Burden of Disease Study 2017  Angela Y Chang, ScD, Prof Vegard F Skirbekk, PhD, Stefanos Tyrovolas,
Volume 393, Issue 10172, Pages (February 2019)
Volume 393, Issue 10172, Pages (February 2019)
Volume 3, Issue 6, Pages (June 2016)
Elder abuse prevalence in community settings: a systematic review and meta-analysis  Yongjie Yon, MA, Christopher R Mikton, PhD, Zachary D Gassoumis, PhD,
Improved social services and the burden of post-traumatic stress disorder among economically vulnerable people after a natural disaster: a modelling study 
Thank you to our diverse (but not diverse enough) reviewers
Volume 11, Issue 3, Pages (March 2010)
Volume 389, Issue 10071, Pages (February 2017)
Volume 6, Issue 3, Pages (March 2019)
Spatial lifecourse epidemiology
Volume 393, Issue 10177, Pages (March 2019)
Effectiveness of strategies to improve health-care provider practices in low-income and middle-income countries: a systematic review  Alexander K Rowe,
Drought and the risk of hospital admissions and mortality in older adults in western USA from 2000 to 2013: a retrospective study  Dr Jesse D Berman,
Volume 391, Issue 10132, Pages (May 2018)
Recurrence after low-dose radioiodine ablation and recombinant human thyroid- stimulating hormone for differentiated thyroid cancer (HiLo): long-term results.
Jean H Humphrey, Andrew J Prendergast  The Lancet Global Health 
Sustaining pneumococcal vaccination after transitioning from Gavi support: a modelling and cost-effectiveness study in Kenya  John Ojal, PhD, Ulla Griffiths,
Improving management of neonatal infections
Long-term trends in child maltreatment in England and Wales, 1858–2016: an observational, time-series analysis  Michelle Degli Esposti, BA, David K Humphreys,
Deriving a practical framework for the evaluation of health apps
Improving lives by accelerating progress towards the UN Sustainable Development Goals for adolescents living with HIV: a prospective cohort study  Prof.
Refining treatment choices for ADHD
Volume 6, Issue 7, Pages (July 2019)
Efficacy of live oral rotavirus vaccines by duration of follow-up: a meta-regression of randomised controlled trials  Andrew Clark, PhD, Kevin van Zandvoort,
Sickle cell disease: a new era
Trends in temperature-related age-specific and sex-specific mortality from cardiovascular diseases in Spain: a national time-series analysis  Hicham Achebak,
Presentation transcript:

Volume 17, Issue 3, Pages 232-240 (March 2018) The Edinburgh CT and genetic diagnostic criteria for lobar intracerebral haemorrhage associated with cerebral amyloid angiopathy: model development and diagnostic test accuracy study  Mark A Rodrigues, FRCR, Neshika Samarasekera, PhD, Christine Lerpiniere, RGN, Catherine Humphreys, MBChB, Mark O McCarron, MD, Prof Philip M White, FRCR, Prof James A R Nicoll, FRCPath, Prof Cathie L M Sudlow, DPhil, Prof Charlotte Cordonnier, PhD, Prof Joanna M Wardlaw, MD, Prof Colin Smith, FRCPath, Prof Rustam Al-Shahi Salman, PhD  The Lancet Neurology  Volume 17, Issue 3, Pages 232-240 (March 2018) DOI: 10.1016/S1474-4422(18)30006-1 Copyright © 2018 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license Terms and Conditions

Figure 1 Pathological severity of CAA and other small vessel disease according to intracerebral haemorrhage location CAA=cerebral amyloid angiopathy. The Lancet Neurology 2018 17, 232-240DOI: (10.1016/S1474-4422(18)30006-1) Copyright © 2018 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license Terms and Conditions

Figure 2 Discrimination and calibration measures of prediction model performance (A) Receiver operating characteristic curve for predicted probability of moderate or severe CAA. The AUC is equivalent to the c statistic. The shaded area represents the 95% CI of the AUC based on 2000 bootstrap replicates. The dotted line indicates a non-informative AUC of 0·50 for comparison. (B) Calibration plot of predicted probability versus observed frequency of moderate or severe CAA. Grey line indicates perfect calibration, the model's calibration is shown by the dotted line. Triangles represent the six different moderate or severe CAA risk groups produced by the prediction model. Vertical lines represent the frequency and distribution of model predicted probabilities. CAA=cerebral amyloid angiopathy. AUC=area under the curve. The Lancet Neurology 2018 17, 232-240DOI: (10.1016/S1474-4422(18)30006-1) Copyright © 2018 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license Terms and Conditions

Figure 3 Categorisation of probability of lobar intracerebral haemorrhage associated with moderate or severe cerebral amyloid angiopathy according to the three predictor variables, with example CT images CAA=cerebral amyloid angiopathy. Adapted from Salman and Rodrigues (Creative Commons 4.0).23 The Lancet Neurology 2018 17, 232-240DOI: (10.1016/S1474-4422(18)30006-1) Copyright © 2018 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license Terms and Conditions